$SVNT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SAVIENT PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in SAVIENT PHARMACEUTICALS INC. Get notifications about new insider transactions in SAVIENT PHARMACEUTICALS INC for free.

Page:   1 2 3 4 5 ... 6 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 05 2013SVNTSAVIENT PHARMACEUT ...THOMPSON VIRGILDirectorSellS0.02106,7512,4550106.8 K to 0 (-100.00 %)
Oct 21 2013SVNTSAVIENT PHARMACEUT ...Constantine GingerDirectorSellS0.078,80563908.8 K to 0 (-100.00 %)
Oct 18 2013SVNTSAVIENT PHARMACEUT ...JAEGER STEPHEN ODirectorSellS0.0538,0611,903038.1 K to 0 (-100.00 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.0910,00091690,545100.5 K to 90.5 K (-9.95 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.1053,4115,245100,545154 K to 100.5 K (-34.69 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.1050,0004,895153,956204 K to 154 K (-24.52 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.1040,0004,000203,956244 K to 204 K (-16.40 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.0920,0001,828243,956264 K to 244 K (-7.58 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.1019,7451,921263,956283.7 K to 264 K (-6.96 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KCo-President and CB ...SellS0.1020,0002,030283,701303.7 K to 283.7 K (-6.59 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.087,64661266,66774.3 K to 66.7 K (-10.29 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.088006474,31375.1 K to 74.3 K (-1.07 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.081,0008075,11376.1 K to 75.1 K (-1.31 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.0821,0001,67076,11397.1 K to 76.1 K (-21.62 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.085,00039697,113102.1 K to 97.1 K (-4.90 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnCo-President and CF ...SellS0.081,500119102,113103.6 K to 102.1 K (-1.45 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardCo-President and CO ...SellS0.08102,5757,796171,750274.3 K to 171.8 K (-37.39 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardCo-President and CO ...SellS0.0811,165843274,325285.5 K to 274.3 K (-3.91 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidChief Accounting Of ...SellS0.0810,00081035,76445.8 K to 35.8 K (-21.85 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidChief Accounting Of ...SellS0.0820,9001,68245,76466.7 K to 45.8 K (-31.35 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidChief Accounting Of ...SellS0.083,00024166,66469.7 K to 66.7 K (-4.31 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidChief Accounting Of ...SellS0.088,50068369,66478.2 K to 69.7 K (-10.87 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidChief Accounting Of ...SellS0.085,47643978,16483.6 K to 78.2 K (-6.55 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.0750036100,000100.5 K to 100 K (-0.50 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.072,400176100,500102.9 K to 100.5 K (-2.33 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.073,500261102,900106.4 K to 102.9 K (-3.29 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.071,600116106,400108 K to 106.4 K (-1.48 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.083,911322108,000111.9 K to 108 K (-3.49 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.0866154111,911112.6 K to 111.9 K (-0.59 %)
Oct 17 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.0865,6395,336112,572178.2 K to 112.6 K (-36.83 %)
May 23 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS0.571,020581307,439308.5 K to 307.4 K (-0.33 %)
May 01 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.741,250925178,211179.5 K to 178.2 K (-0.70 %)
May 01 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Chief Operatin ...SellS0.742,4851,839285,490288 K to 285.5 K (-0.86 %)
Mar 08 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & Chief Ac ...SellS0.931,5601,45183,64085.2 K to 83.6 K (-1.83 %)
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & Chief Ac ...GrantA0.0029,000085,20056.2 K to 85.2 K (+51.60 %)
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Veitch DavidPresidentOption ExerciseA0.94162,500152,750162,500
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Veitch DavidPresidentOption ExerciseA0.94110,000103,400110,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...Option ExerciseA2.2678,000176,28078,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...Option ExerciseA0.94110,000103,400110,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Hamill JohnSVP, CFOOption ExerciseA0.94110,000103,400110,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOOption ExerciseA0.56150,00084,000150,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOOption ExerciseA2.2660,200136,05260,200
Mar 07 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOOption ExerciseA0.94180,000169,200180,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...Option ExerciseA11.6225,000290,50025,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...Option ExerciseA2.26100,000226,000100,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...Option ExerciseA0.94110,000103,400110,000
Feb 25 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS0.99375371295,996296.4 K to 296 K (-0.13 %)
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...Option ExerciseA7.0050,000350,00050,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...Option ExerciseA2.2690,000203,40090,000
Mar 07 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...Option ExerciseA0.94110,000103,400110,000
Feb 06 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS1.0421,70022,568171,750193.5 K to 171.8 K (-11.22 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS1.017,3007,373193,450200.8 K to 193.5 K (-3.64 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...SellS1.0530,00031,500287,975318 K to 288 K (-9.43 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...SellS1.0118,90019,089317,975336.9 K to 318 K (-5.61 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS1.023,2003,264296,371299.6 K to 296.4 K (-1.07 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS1.0159,00059,590299,571358.6 K to 299.6 K (-16.45 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...SellS1.023,2033,267303,701306.9 K to 303.7 K (-1.04 %)
Feb 06 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...SellS1.0127,29727,570306,904334.2 K to 306.9 K (-8.17 %)
Feb 04 2013SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS1.031,3001,339200,750202.1 K to 200.8 K (-0.64 %)
Feb 04 2013SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...SellS1.022,4152,463336,875339.3 K to 336.9 K (-0.71 %)
Jan 17 2013SVNTSAVIENT PHARMACEUT ...Meeker David PDirectorOption ExerciseA1.1716,41519,20616,415
Jan 17 2013SVNTSAVIENT PHARMACEUT ...Meeker David PDirectorGrantA1.1712,64414,79312,6440 to 12.6 K
Jan 16 2013SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...SellS1.141,2831,463334,201335.5 K to 334.2 K (-0.38 %)
Dec 07 2012SVNTSAVIENT PHARMACEUT ...Savage Robert G.DirectorOption ExerciseA1.1421,01323,95521,013
Dec 07 2012SVNTSAVIENT PHARMACEUT ...Savage Robert G.DirectorGrantA1.1416,14918,41016,1490 to 16.1 K
Nov 27 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS1.169501,102358,571359.5 K to 358.6 K (-0.26 %)
Nov 27 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOGrantA1.122,4342,731359,521357.1 K to 359.5 K (+0.68 %)
Nov 27 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOGrantA0.625,8883,625357,087351.2 K to 357.1 K (+1.68 %)
Nov 27 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOGrantA1.712,6224,480351,199348.6 K to 351.2 K (+0.75 %)
Nov 06 2012SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...SellS1.452,0102,915339,290341.3 K to 339.3 K (-0.59 %)
Nov 06 2012SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS1.451,0001,450202,050203.1 K to 202.1 K (-0.49 %)
Sep 26 2012SVNTSAVIENT PHARMACEUT ...Hamill JohnSVP, CFOOption ExerciseA2.92250,000730,000250,000
Sep 26 2012SVNTSAVIENT PHARMACEUT ...Hamill JohnSVP, CFOGrantA2.92100,000292,000100,0000 to 100 K
Aug 24 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOSellS1.00984986348,577349.6 K to 348.6 K (-0.28 %)
Aug 03 2012SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharma Oper ...SellS0.622,5001,550341,300343.8 K to 341.3 K (-0.73 %)
Aug 03 2012SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...SellS0.624,9503,069203,050208 K to 203.1 K (-2.38 %)
Jul 20 2012SVNTSAVIENT PHARMACEUT ...Norton David YDirectorOption ExerciseA0.5682,45846,17682,458
Jul 20 2012SVNTSAVIENT PHARMACEUT ...Norton David YDirectorGrantA0.5662,03534,74069,2847.2 K to 69.3 K (+855.77 %)
Jul 11 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISPresident and CEOOption ExerciseA0.56150,00084,000150,000
May 24 2012SVNTSAVIENT PHARMACEUT ...JAEGER STEPHEN ODirectorOption ExerciseA0.81139,456112,959139,456
May 24 2012SVNTSAVIENT PHARMACEUT ...JAEGER STEPHEN ODirectorGrantA0.8198,76580,000165,41066.6 K to 165.4 K (+148.20 %)
May 24 2012SVNTSAVIENT PHARMACEUT ...Owen William FDirectorOption ExerciseA0.8169,72856,48069,728
May 24 2012SVNTSAVIENT PHARMACEUT ...Owen William FDirectorGrantA0.8149,38239,99956,6317.2 K to 56.6 K (+681.22 %)
May 24 2012SVNTSAVIENT PHARMACEUT ...THOMPSON VIRGILDirectorOption ExerciseA0.8169,72856,48069,728
May 24 2012SVNTSAVIENT PHARMACEUT ...THOMPSON VIRGILDirectorGrantA0.8149,38239,999109,57560.2 K to 109.6 K (+82.04 %)
May 24 2012SVNTSAVIENT PHARMACEUT ...Constantine GingerDirectorOption ExerciseA0.8169,72856,48069,728
May 24 2012SVNTSAVIENT PHARMACEUT ...Constantine GingerDirectorGrantA0.8149,38239,99965,01515.6 K to 65 K (+315.88 %)
May 22 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, North American ...SellS0.82942772349,561350.5 K to 349.6 K (-0.27 %)
May 01 2012SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP Biopharmaceutic ...SellS2.359,20021,620343,800353 K to 343.8 K (-2.61 %)
Feb 29 2012SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...GrantA2.10100,000210,000335,484235.5 K to 335.5 K (+42.47 %)
Feb 23 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, North American ...SellS2.064,1008,446350,503354.6 K to 350.5 K (-1.16 %)
Feb 23 2012SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...SellS2.023,5407,151235,484239 K to 235.5 K (-1.48 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...Option ExerciseA2.26100,000226,000100,000
Feb 13 2012SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...GrantA2.26150,000339,000208,00058 K to 208 K (+258.62 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...Option ExerciseA2.26100,000226,000100,000
Feb 13 2012SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP, Biopharmaceuti ...GrantA2.26250,000565,000353,000103 K to 353 K (+242.72 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...Option ExerciseA2.26100,000226,000100,000
Feb 13 2012SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...GrantA2.2650,000113,000239,024189 K to 239 K (+26.45 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...ZUERBLIS KENNETH JEVP, Chief Financia ...Option ExerciseA2.26100,000226,000100,000
Feb 13 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, N American Com ...Option ExerciseA2.26100,000226,000100,000
Feb 13 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, N American Com ...GrantA3.6622281344,22244 K to 44.2 K (+0.50 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, N American Com ...GrantA2.1338181244,60344.2 K to 44.6 K (+0.86 %)
Feb 13 2012SVNTSAVIENT PHARMACEUT ...FERRARI LOUISEVP, N American Com ...GrantA2.26310,000700,600354,60344.6 K to 354.6 K (+695.02 %)
Jan 04 2012SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNChief Executive Off ...SellS2.3017,65040,595252,350270 K to 252.4 K (-6.54 %)
Nov 22 2011SVNTSAVIENT PHARMACEUT ...FERRARI LOUISSVP, North American ...BuyP2.294,0009,16044,00040 K to 44 K (+10.00 %)
Nov 22 2011SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP Biopharmaceutic ...BuyP2.533,0007,590103,000100 K to 103 K (+3.00 %)
Nov 22 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP2.305,00011,500270,000265 K to 270 K (+1.89 %)
Nov 21 2011SVNTSAVIENT PHARMACEUT ...ZUERBLIS KENNETH JEVP, Chief Financia ...BuyP2.352,0004,6907,0005 K to 7 K (+40.00 %)
Nov 21 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP2.2810,00022,800265,000255 K to 265 K (+3.92 %)
Nov 21 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP2.361,0002,3604,0003 K to 4 K (+33.33 %)
Nov 18 2011SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...BuyP2.595,00012,94558,00053 K to 58 K (+9.43 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...HELLER ALAN LDirectorBuyP3.997,50029,92540,17932.7 K to 40.2 K (+22.95 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...BuyP3.975001,98353,00052.5 K to 53 K (+0.95 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...BuyP3.952,5009,87152,50050 K to 52.5 K (+5.00 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP4.091,5006,1353,0001.5 K to 3 K (+100.00 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP4.1025,000102,493255,000230 K to 255 K (+10.87 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNCEO & PresidentBuyP3.881,5005,8241,5000 to 1.5 K
Sep 16 2011SVNTSAVIENT PHARMACEUT ...ZUERBLIS KENNETH JEVP, Chief Financia ...BuyP4.054,00016,1905,0001,000 to 5 K (+400.00 %)
Sep 16 2011SVNTSAVIENT PHARMACEUT ...ZUERBLIS KENNETH JEVP, Chief Financia ...BuyP3.971,0003,9701,0000 to 1,000
Sep 16 2011SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...BuyP4.137,00028,910189,024182 K to 189 K (+3.85 %)
Sep 14 2011SVNTSAVIENT PHARMACEUT ...ZUERBLIS KENNETH JEVP, Chief Financia ...Option ExerciseA3.81300,0001,143,000300,000
Sep 06 2011SVNTSAVIENT PHARMACEUT ...Owen William FDirectorOption ExerciseA4.019,50538,1159,505
Sep 06 2011SVNTSAVIENT PHARMACEUT ...Owen William FDirectorGrantA4.017,24929,0687,2490 to 7.2 K
Sep 06 2011SVNTSAVIENT PHARMACEUT ...Norton David YDirectorOption ExerciseA4.019,50538,1159,505
Sep 06 2011SVNTSAVIENT PHARMACEUT ...Norton David YDirectorGrantA4.017,24929,0687,2490 to 7.2 K
Aug 02 2011SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...Option ExerciseA7.00150,0001,050,000150,000
Aug 02 2011SVNTSAVIENT PHARMACEUT ...Bahrt KennethSVP, Chief Medical ...GrantA7.0050,000350,00050,000100 K to 50 K (-50.00 %)
May 31 2011SVNTSAVIENT PHARMACEUT ...Constantine GingerDirectorOption ExerciseA7.787,03154,7017,031
May 31 2011SVNTSAVIENT PHARMACEUT ...Constantine GingerDirectorGrantA7.785,29141,16415,63310.3 K to 15.6 K (+51.16 %)
May 31 2011SVNTSAVIENT PHARMACEUT ...Simon Lee SDirectorOption ExerciseA7.787,03154,7017,031
May 31 2011SVNTSAVIENT PHARMACEUT ...Simon Lee SDirectorGrantA7.785,29141,16429,17923.9 K to 29.2 K (+22.15 %)
May 31 2011SVNTSAVIENT PHARMACEUT ...HELLER ALAN LDirectorOption ExerciseA7.787,03154,7017,031
May 31 2011SVNTSAVIENT PHARMACEUT ...HELLER ALAN LDirectorGrantA7.785,29141,16432,67927.4 K to 32.7 K (+19.32 %)
May 31 2011SVNTSAVIENT PHARMACEUT ...THOMPSON VIRGILDirectorOption ExerciseA7.787,03154,7017,031
May 31 2011SVNTSAVIENT PHARMACEUT ...THOMPSON VIRGILDirectorGrantA7.785,29141,16460,19354.9 K to 60.2 K (+9.64 %)
May 03 2011SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP Biopharmaceutic ...Option ExerciseA11.6250,000581,00050,000
May 03 2011SVNTSAVIENT PHARMACEUT ...CROWLEY RichardEVP Biopharmaceutic ...GrantA11.62100,0001,162,000100,000200 K to 100 K (-50.00 %)
May 31 2011SVNTSAVIENT PHARMACEUT ...JAEGER STEPHEN ODirectorOption ExerciseA7.7814,062109,40214,062
May 31 2011SVNTSAVIENT PHARMACEUT ...JAEGER STEPHEN ODirectorGrantA7.7810,58282,32866,64556.1 K to 66.6 K (+18.88 %)
Feb 23 2011SVNTSAVIENT PHARMACEUT ...FERRARI LOUISSVP, North American ...Option ExerciseA9.98100,000998,000100,000
Feb 23 2011SVNTSAVIENT PHARMACEUT ...FERRARI LOUISSVP, North American ...GrantA9.9840,000399,20040,0000 to 40 K
Feb 15 2011SVNTSAVIENT PHARMACEUT ...YACHMETZ PHILIP KSVP, General Counse ...SellS9.883,21031,724182,024185.2 K to 182 K (-1.73 %)
Feb 15 2011SVNTSAVIENT PHARMACEUT ...Hamelin PaulPresidentSellS9.895,37153,117124,765130.1 K to 124.8 K (-4.13 %)
Feb 02 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNChief Executive Off ...Option ExerciseA9.23250,0002,307,500250,000
Feb 02 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNChief Executive Off ...GrantA9.23230,0002,122,900230,0000 to 230 K
Feb 02 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNChief Executive Off ...Option ExerciseA9.23250,0002,307,500250,000
Feb 02 2011SVNTSAVIENT PHARMACEUT ...JOHNSON JOHNChief Executive Off ...GrantA9.23230,0002,122,900230,0000 to 230 K
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOSellS10.002,03220,32042,73544.8 K to 42.7 K (-4.54 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA10.037373244,76744.7 K to 44.8 K (+0.16 %)
Jan 27 2011SVNTSAVIENT PHARMACEUT ...Gionco DavidGroup VP & CFOGrantA11.956071744,69444.6 K to 44.7 K (+0.13 %)

Page:   1 2 3 4 5 ... 6 next >

Contact us | Follow us on Twitter